Hormone treatment may help prevent premature menopause in cancer patients

Young women with breast cancer who are given a luteinising hormone releasing hormone (LHRH) analogue, triptorelin, alongside chemotherapy are more likely to retain ovarian function, a study in JAMA shows.1

Early menopause and impaired fertility are possible consequences of cancer treatment. This can add to a patient’s distress and may also affect treatment decisions. Freezing eggs or embryos is the standard procedure for fertility preservation in patients with cancer. Administering LHRH analogues during chemotherapy to …